Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein Medical (Nasdaq: HSIC) has opened nominations for its 2025 Athletics and Schools Rising Star Award, celebrating National Athletic Training Month in March. The annual award, established in 2021, recognizes emerging athletic trainers with 1-5 years of experience who show strong career potential.
Three finalists will be selected by March 11, 2025, through peer nominations submitted by March 5, 2025. Public voting will occur on Henry Schein's social media platforms from March 19-25, 2025. The winner, to be announced on March 27, 2025, will receive a MARC PRO muscle stimulator and a Medi Kit™ MULE roller bag with athletic training supplies.
The previous year's award recipient was Aline Valiengo, Head Athletic Trainer and Director of Sports Medicine at Coconut Creek High School in Florida.
Henry Schein (Nasdaq: HSIC) reported its Q4 and full-year 2024 financial results, with Q4 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19. The company achieved Q4 operating cash flow of $204 million and full-year operating cash flow of $848 million, up $348 million from 2023.
For 2025, Henry Schein expects non-GAAP diluted EPS between $4.80 and $4.94 with mid-single digit Adjusted EBITDA growth and total sales growth of 2-4%. The company announced a new organizational structure with three reportable segments: Global Distribution and Value-Added Services ($10.8B annual sales), Global Specialty Products ($1.4B), and Global Technology ($0.6B).
Q4 total net sales were $3.2 billion, up 5.8% year-over-year, reflecting 5.5% internal growth. Full-year 2024 sales reached $12.7 billion, a 2.7% increase. The company recorded $37 million in restructuring costs in Q4, with activities expected to provide over $80 million in annual run-rate savings.
Henry Schein (Nasdaq: HSIC) announced that Stanley M. Bergman, Chairman of the Board and CEO, received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime Achievement Award. The recognition honors individuals who have demonstrated exceptional leadership, service, and engagement with NAW and the distribution community.
Bergman received the award at the 2025 NAW Executive Summit Gala on January 28 in Washington, D.C. The NAW represents the $8.2 trillion wholesale distribution industry, which employs over 6 million workers across 35,000 companies operating in nearly 150,000 locations throughout North America.
Give Kids A Smile (GKAS) program is celebrating its 23rd year of providing free oral healthcare to underserved children, with its 2025 national kick-off event at Meharry Medical College School of Dentistry. Since 2003, GKAS volunteers have served over 9.5 million children in the U.S.
In 2025, nearly 1,100 GKAS events are scheduled nationwide, expecting to serve approximately 325,500 underserved children through free oral health education, screenings, and preventive services. About 25,000 dental professionals will volunteer, supported by donations from Henry Schein (HSIC) and Colgate-Palmolive.
Henry Schein has contributed over $20 million in oral health care products since the program's inception. The initiative addresses a critical need, as CDC data shows 50% of children aged 6-9 years have had cavities, with lower-income children being twice as likely to have untreated cavities compared to higher-income households.
Henry Schein Medical (Nasdaq: HSIC) celebrated National Girls and Women in Sports Day 2025 by launching a video featuring four prominent WNBA athletic trainers. The video highlights Theresa Acosta (New York Liberty), Dr. Christina Kennedy (Washington Mystics), Natalie Trotter (Women's Professional Basketball Athletic Trainers Association), and Brittanie Vaughn (Seattle Storm).
The interviews explore their memorable career moments, the increasing presence of women in sports, and career advice. This marks the third year of Henry Schein Medical's Athletics and Schools business producing videos celebrating women athletic trainers, having featured 14 women ATs from three professional sports leagues to date.
The initiative aims to recognize athletic trainers' important role in athlete care and highlight the growing representation of women in sports medicine. In 2024, the company featured athletic trainers from five NBA teams.
Henry Schein (HSIC) announced a strategic investment from KKR, which will become the company's largest non-index fund shareholder with a 12% position through a $250 million investment. KKR can increase its stake to 14.9% through open market purchases.
The company reported preliminary Q4 2024 results with revenue of $3.2 billion and full-year 2024 revenue of $12.7 billion. Q4 GAAP EPS was $0.74, while non-GAAP EPS reached $1.19. Full-year 2024 GAAP EPS was $3.05, with non-GAAP EPS at $4.74.
For 2025, Henry Schein projects low to mid-single digit growth in both revenues and non-GAAP EPS. The company also announced a $500 million increase to its share repurchase program, with $250 million to be executed through accelerated share repurchases.
Henry Schein (NASDAQ: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its upcoming fourth quarter and full-year 2024 financial results release and conference call.
The company will release its financial results before market opening on Tuesday, February 25, 2025. A live webcast earnings conference call will follow at 8:00 a.m. Eastern time. The call will feature presentations from Stanley M. Bergman, Chairman of the Board and CEO, and Ronald N. South, Senior Vice President and CFO.
Investors can access the webcast through the company's investor relations website at https://investor.henryschein.com/webcasts. A replay of the presentation will be made available on the website afterward.
Henry Schein (HSIC) has completed the acquisition of substantially all assets of Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs). The deal, initially announced on November 20, 2024, brings Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia into Henry Schein's team, incorporating their healthcare industry and product expertise.
The transaction was facilitated by Provident Healthcare Partners, with their deal team led by Managing Director Kevin Palamara. Robinson & Cole provided legal counsel to Acentus during the acquisition process. Acentus has developed a distinctive CGM platform that has shown significant growth since its establishment.
Henry Schein (Nasdaq: HSIC) has completed the acquisition of Acentus, a Tampa-based national medical supplier specializing in Continuous Glucose Monitors (CGMs) with annual revenue of approximately $35 million. The transaction is expected to be neutral to 2025 non-GAAP earnings per share and accretive thereafter.
This acquisition follows Henry Schein's previous acquisitions of Prism Medical Products (2021), Shield Healthcare, and Mini Pharmacy (2023), strengthening its position in the homecare medical supplies market. With the addition of Acentus, Henry Schein's homecare medical products platform will now have an annual revenue base exceeding $350 million.
The four Acentus founders will join Henry Schein, bringing their expertise in the product category and healthcare industry. The acquisition aims to enhance Henry Schein's ability to serve customers through direct CGM product delivery to patients' homes.
Henry Schein (Nasdaq: HSIC) has announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support Los Angeles area fires relief efforts. The initiative includes a total commitment of up to $300,000, comprising:
- $25,000 each from the Company and Foundation
- Up to $50,000 in matching Team Schein Member contributions
- Up to $150,000 in essential healthcare supplies
The company has established a Customer Emergency Support Hotline (800-999-9729) for affected dental and medical professionals. The initiative aims to provide critical healthcare supplies and resources to communities impacted by the wildfires, working with trusted relief and recovery charitable partners.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
